[1]
T. Kubaisi and K. . Sharquie, “The impact of COVID-19 infection on botulinum toxin hypersensitivity: Case report and literature review”, J Pak Assoc Dermatol, vol. 33, no. 4, pp. 1762–1766, Oct. 2023.